消息
×
loading..
Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth
2022-02-01
发表期刊NATURE METABOLISM (IF:18.9[JCR-2023],21.0[5-Year])
EISSN2522-5812
发表状态已发表
DOI10.1038/s42255-021-00524-2
摘要["Tumors can reprogram the functions of metabolic enzymes to fuel malignant growth; however, beyond their conventional functions, key metabolic enzymes have not been found to directly govern cell mitosis. Here, we report that glutamine synthetase (GS) promotes cell proliferation by licensing mitotic progression independently of its metabolic function. GS depletion, but not impairment of its enzymatic activity, results in mitotic arrest and multinucleation across multiple lung and liver cancer cell lines, patient-derived organoids and xenografted tumors. Mechanistically, GS directly interacts with the nuclear pore protein NUP88 to prevent its binding to CDC20. Such interaction licenses activation of the CDC20-mediated anaphase-promoting complex or cyclosome to ensure proper metaphase-to-anaphase transition. In addition, GS is overexpressed in human non-small cell lung cancer and its depletion reduces tumor growth in mice and increases the efficacy of microtubule-targeted chemotherapy. Our findings highlight a moonlighting function of GS in governing mitosis and illustrate how an essential metabolic enzyme promotes cell proliferation and tumor development, beyond its main metabolic function.","Zhao et al. report a role for glutamine synthetase in regulating cell proliferation that does not require the catalytic activity of the enzyme."]
URL查看原文
收录类别SCI ; SCIE
语种英语
资助项目Ministry of Science and Technology of the People's Republic of China[2020YFA0803300] ; National Natural Science Foundation of China[31871369,32011530396,82188102] ; Zhejiang Provincial Natural Science Foundation of China[LD19H160002] ; Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang[2019R01001] ; Czech Science Foundation[18-24473Y]
WOS研究方向Endocrinology & Metabolism
WOS类目Endocrinology & Metabolism
WOS记录号WOS:000753764600001
出版者NATURE PORTFOLIO
引用统计
正在获取...
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/159560
专题免疫化学研究所_特聘教授组_干细胞生物学实验室
通讯作者Zhao, Jiang-Sha; Liang, Tingbo; Lu, Zhimin; Feng, Yu-Xiong
作者单位
1.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Peoples R China
2.Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou, Peoples R China
3.Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China
4.ShanghaiTech Univ, Shanghai Adv Inst Immunochem Studies, Shanghai, Peoples R China
5.Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic
6.Chinese Acad Sci, Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp,Inst Canc & Basic Med,Dept Thorac Radio, Hangzhou, Peoples R China
7.Chinese Acad Sci, Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp,Dept Med Oncol,Inst Canc & Basic Med, Hangzhou, Peoples R China
8.Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA
9.Ohio State Univ, Coll Med, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA
10.Zhejiang Univ, Life Sci Inst, Hangzhou, Peoples R China
11.Westlake Univ, Sch Life Sci, Hangzhou, Peoples R China
12.Univ Texas Houston, MD Anderson Canc Ctr UTHlth Grad Sch Biomed Sci, Houston, TX USA
推荐引用方式
GB/T 7714
Zhao, Jiang-Sha,Shi, Shuo,Qu, Hai-Yan,et al. Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth[J]. NATURE METABOLISM,2022.
APA Zhao, Jiang-Sha.,Shi, Shuo.,Qu, Hai-Yan.,Keckesova, Zuzana.,Cao, Zi-Jian.,...&Feng, Yu-Xiong.(2022).Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth.NATURE METABOLISM.
MLA Zhao, Jiang-Sha,et al."Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth".NATURE METABOLISM (2022).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Zhao, Jiang-Sha]的文章
[Shi, Shuo]的文章
[Qu, Hai-Yan]的文章
百度学术
百度学术中相似的文章
[Zhao, Jiang-Sha]的文章
[Shi, Shuo]的文章
[Qu, Hai-Yan]的文章
必应学术
必应学术中相似的文章
[Zhao, Jiang-Sha]的文章
[Shi, Shuo]的文章
[Qu, Hai-Yan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。